ArticleBMJ open2017
High adherence to the 'Wise List' treatment recommendations in Stockholm: a 15-year retrospective review of a multifaceted approach promoting rational use of medicines.
Article in BMJ open, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
52 citing papers in PubMed.
- A combined strategies intervention on the World Health Organization prescribing indicators: A quasi-randomised trial.African journal of primary health care & family medicine · 2024Trial
- Appraising the visibility, relevance and impacts of clinical pharmacology.British journal of clinical pharmacology · 2025Review
- Towards greener prescribing? Swedish general practitioners' support for policies to reduce pharmaceutical pollution.British journal of clinical pharmacology · 2025Article
- Towards greener prescribing? Swedish general practitioners' support for policies to reduce pharmaceutical pollution.British journal of clinical pharmacology · 2025Article
- So Many Choices, So Little Value: Potential Savings from Selecting Cost-Effective Proton Pump Inhibitors.PharmacoEconomics - open · 2025Article
- Clinical pharmacogenetics: A feasibility study of pharmacy students using a clinical decision support system during their didactic training.Innovations in pharmacy · 2025Article
- A Narrative Review of Recent Antibiotic Prescribing Practices in Ambulatory Care in Tanzania: Findings and Implications.Medicina (Kaunas, Lithuania) · 2023Review
- Specific features of rational pharmacotherapy in elderly patients.European journal of hospital pharmacy : science and practice · 2023Article
- A Narrative Review of Antibiotic Prescribing Practices in Primary Care Settings in South Africa and Potential Ways Forward to Reduce Antimicrobial Resistance.Antibiotics (Basel, Switzerland) · 2023Article
- Knowledge support for environmental information on pharmaceuticals: experiences among Swedish Drug and Therapeutics Committees.BMC health services research · 2023Article
- Knowledge, attitudes and practices of healthcare professionals on the use of an electronic stock visibility and management tool in a middle-income country: Implications for access to medicines.Exploratory research in clinical and social pharmacy · 2023Article
- Regional variations in excessive polypharmacy and potentially inappropriate drug use among older adults in Sweden: Trends from 2006 to 2020.Frontiers in pharmacology · 2023Article
- Trends in the Cost of Medicines, Consultation Fees and Clinic Visits in Malaysia's Private Primary Healthcare System: Employer Health Insurance Coverage.Journal of multidisciplinary healthcare · 2023Article
- Ongoing Efforts to Improve Antimicrobial Utilization in Hospitals among African Countries and Implications for the Future.Antibiotics (Basel, Switzerland) · 2022Article
- Determinants of the Empiric Use of Antibiotics by General Practitioners in South Africa: Observational, Analytic, Cross-Sectional Study.Antibiotics (Basel, Switzerland) · 2022Article
- Acceptability of a short list of essential medicines to patients and prescribers: Multimethod study.Canadian family physician Medecin de famille canadien · 2022Article
- Forming a medicines pricing policy for low and middle-income countries (LMICs): the case for Pakistan.Journal of pharmaceutical policy and practice · 2022Article
- Demand of COVID-19 medicines without prescription among community pharmacies in Jodhpur, India: Findings and implications.Journal of family medicine and primary care · 2022Article
- Antimicrobial Stewardship Activities in Public Healthcare Facilities in South Africa: A Baseline for Future Direction.Antibiotics (Basel, Switzerland) · 2021Article
- Assessing variation among the national essential medicines lists of 21 high-income countries: a cross-sectional study.BMJ open · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo present the 'Wise List' (a formulary of essential medicines for primary and specialised care in Stockholm Healthcare Region) and assess adherence to the recommendations over a 15-year period.
designRetrospective analysis of all prescription data in the Stockholm Healthcare Region between 2000 and 2015 in relation to the Wise List recommendations during the same time period.
settingAll outpatient care in the Stockholm Healthcare Region.
participantsAll prescribers in the Stockholm Healthcare Region.
main outcome measuresThe number of core and complementary substances included in the Wise List, the adherence to recommendations by Anatomic Therapeutic Chemical (ATC) 1st level using defined daily doses (DDDs) adjusted to the DDD for 2015, adherence to recommendations over time measured by dispensed prescriptions yearly between 2002 and 2015.
resultsThe number of recommended core substances was stable (175-212). Overall adherence to the recommendations for core medicines for all prescribers increased from 75% to 84% (2000 to 2015). The adherence to recommendations in primary care for core medicines increased from 80% to 90% (2005 to 2015) with decreasing range in practice variation (32% to 13%). Hospital prescriber adherence to core medicine recommendations was stable but increased for the combination core and complementary medicines from 77% to 88% (2007 to 2015). Adherence varied between the 4 therapeutic areas studied.
conclusionsHigh and increasing adherence to the Wise List recommendations was seen for all prescriber categories. The transparent process for developing recommendations involving respected experts and clinicians using strict criteria for handling potential conflicts of interests, feedback to prescribers, continuous medical education and financial incentives are possible contributing factors. High-quality evidence-based recommendations to prescribers, such as the Wise List, disseminated through a multifaceted approach, will become increasingly important and should be developed further to include recommendations and introduction protocols for new expensive medicines.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.